Skip to content

Effectiveness of Wild rue shampoo in the treatment of head lice

Clinical efficacy investigation and comparison of shampoo containing Peganum harmala extract and permethrin shampoo in patients with head lice

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160306026938N20
Enrollment
40
Registered
2024-08-27
Start date
2024-08-24
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head lice. Pediculosis due to Pediculus humanus capitis

Interventions

Intervention 1: Intervention group: The recipient of shampoo containing Peganum harmala extract. Patients use the Peganum harmala shampoo product once a day and every time by smearing all the affected

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 65 Years

Inclusion criteria

Inclusion criteria: Conformity with head lice diagnostic criteria. Age range between 7 and 65 years. Being in healthy condition Signing informed consent form for adults and parental consent form for children Not using local or systemic anti-lice products during the recent infection

Exclusion criteria

Exclusion criteria: Local or systemic anti-lice treatment or use of hair dye during or before the study period Having serious diseases or extensive wounds, especially in the scalp area (such as impetigo or eczema), chronic scalp disorders (such as psoriasis, chronic dermatosis)and secondary scalp infection Known allergy to any of the components of the product Treatment with antibiotics (cotrimoxazole, trimethoprim, tetracycline) or anti-worm (such as ivermectin, levamisole, albendazole) in the last 1 month or other local or systemic drugs that may lead to errors in the test.

Design outcomes

Primary

MeasureTime frame
Lice levels. Timepoint: Before the initiation of intervention and the day after the last application of formulation. Method of measurement: Scoring the patients' symptoms based on a 0-10 Likert scale with regard to improvements in symptoms(0=no improvement; 10=complete improvement).

Secondary

MeasureTime frame
Quality of life. Timepoint: Before the start of the intervention and one day after the last use of the formulation. Method of measurement: Completion of a 30-question questionnaire on the quality of life of head lice patients by the patient.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdi Vazirian

Tehran University of Medical Sciences

Vazirian_m@tums.ac.ir+98 21 6412 1223

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026